Health

Quin Denfeld, PhD, discusses her findings from the BIOMES-HF study, indicating worsening symptoms in patients with HF over time. Although dyspnea generally improves in patients after heart failure (HF) hospitalization, symptoms can remain persistent or worsen in >1/3 of all cases, according to data from the BIOMES-HF study.1 Quin Denfeld, PhD, associate professor at Oregon Health & Science University, presented these data at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2026 in Phoenix, Arizona, by Quin Denfeld, PhD, associate professor at Oregon Health & Science University. In an interview with HCPLive, Denfeld discussed the implications of her research and why these symptoms are critically important.1“The cardinal symptom of heart failure is dyspnea, or shortness of breath. That’s what brings people into the hospital,” Denfeld told HCPLive. “We wanted to see, after that hospitalization, how did these patients fare afterwards in terms of their dyspnea? Did it go up? Did it go down?

Photo: Cathy Yeulet/Hemera/ThinkstockToronto — Researchers from the Institute for Work and Health recently set out to learn if employees with a physical or mental health issue tell their employer about their condition and if they try to hide its impact on their work. They surveyed 695 adult workers with physical or mental health/cognitive conditions that limited their ability – to some degree – to meet job demands.

Headaches. Back pain. Abdominal pain. Knee pain. Across every body site researchers examined, women reported pain more often than men. That pattern emerged from a new Nature Medicine analysis of 6.1 million people across 118 countries, making it one of the largest attempts yet to map how pain is reported around the world. The differences were especially striking for some types of pain. Women were 83% more likely than men to report facial pain, 74% more likely to report headaches and 60% more likely to report abdominal pain. Six Million People Reveal A PatternPublished in Nature Medicine, the analysis brought together individual-level pain data from 6,125,459 people, drawn from 902 population-based sources covering 118 countries and territories. Researchers looked at 11 body sites, including the head, face, neck and shoulder, chest, back, abdomen, hip, knee, elbow, hand and wrist, and foot and ankle. Women were more likely than men to report pain at all 11 sites. The difference was not small everywhere. Depending on the location, women had between 1.08 and 1.83 times the likelihood of reporting pain compared with men.

HealthThe World Health Organization (WHO) is strengthening Ebola preparedness amid conflict and displacement affecting millions of lives in a region that spans parts of Africa, Asia and Europe. The UN agency’s eastern Mediterranean region comprises 22 countries and territories. Intensified support is being given to Djibouti, Somalia and Sudan, which have been identified as priority countries. This follows deadly outbreaks of Ebola disease caused by the Bundibugyo virus in both the Democratic Republic of the Congo (DRC) and Uganda and confirmation of a case in Kenya linked to the DRC.

Three measles-related deaths have been reported in England in 2026. One child died from an acute infection, another from the long-term effects of measles, and an adult with an underlying immune condition also died.

Lambton Public Health is offering additional flu and COVID-19 vaccine clinics this season, along with those offered by pharmacies and health care providers. The additional clinics by the local public health agency come at the direction of the Ministry of Health, said Carshenan Lai, the agency’s health protection supervisor.

(MedPage Today) -- Women exposed to anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies for migraine prevention early in their pregnancies had a higher risk of spontaneous abortion, retrospective U.S. data showed. Among 7,100 pregnant...

Fasting can help some people reduce how many calories they eat - but it's not 'effortless' as some influencers would have you believe Intermittent fasting can help people lose weight - but the research behind purported benefits, like improvements in cognitive health, is sparse.

With Alberta seeing an early start to the flu season, residents are taking advantage of the province allowing pharmacies to administer doses earlier than planned. Heather and Hank Nottebrock were given the flu vaccine Thursday.

The American Academy of Otolaryngology – Head and Neck Surgery Foundation has included Lenire (bimodal neuromodulation) as a treatment option for the first time in their Clinical Practice Guidelines for Tinnitus. Lenire is the only new treatment recommendation added to the guidelines since its establishment in 2014.

Some of the most popular travel destinations for Australians are also places where dengue is common.

LONDON, Oct. 16 (Xinhua) -- British researchers are bringing artificial intelligence (AI), automated laboratories and supercomputing together to accelerate the development of personalized cancer vaccines. The effort aims to test whether a more connected research process can shorten the journey from identifying a tumor target to treating a patient. The University of Oxford announced early this month that the Advanced Research and Invention Agency (ARIA) was providing an additional 8 million pounds (about 10.6 million U. S. dollars) for the university's UK Cancer Vaccine AI Scientist and Supercomputing Project. The project combines AI tools for selecting vaccine targets with automated laboratory experiments and data analysis, under the guidance of oncologists. "AI gives us an extraordinary opportunity to find vaccine targets faster and learn from every experiment," said Dr Lennard Lee at Oxford's Center for Immuno-Oncology. Personalized cancer vaccines aim to direct a patient's immune system against their tumor. A central challenge is identifying tumor fragments that will trigger an effective immune response.

LONDON, Oct. 16 (Xinhua) -- British researchers are bringing artificial intelligence (AI), automated laboratories and supercomputing together to accelerate the development of personalized cancer vaccines. The effort aims to test whether a more connected research process can shorten the journey from identifying a tumor target to treating a patient. The University of Oxford announced early this month that the Advanced Research and Invention Agency (ARIA) was providing an additional 8 million pounds (about 10.6 million U. S. dollars) for the university's UK Cancer Vaccine AI Scientist and Supercomputing Project. The project combines AI tools for selecting vaccine targets with automated laboratory experiments and data analysis, under the guidance of oncologists. "AI gives us an extraordinary opportunity to find vaccine targets faster and learn from every experiment," said Dr Lennard Lee at Oxford's Center for Immuno-Oncology. Personalized cancer vaccines aim to direct a patient's immune system against their tumor. A central challenge is identifying tumor fragments that will trigger an effective immune response.

'I'm happy to be a guinea pig in cancer screening trial'7 hours agoDavid SavilleNorth WestCancer Research UKSenior research nurse Irene Debiram-Beecham is giving patients the procedure from a mobile unitA man who volunteered for a pioneering cancer screening trial has said he's "more than happy to be a guinea pig" if it helps others in the future. Paul Burrows, 70, from Inskip, Fylde, is among people recruited to test a new "pill-on-a-thread" device which researchers hope could pave the way for national screening that could transform the early detection of oesophageal cancer. The trial, backed by Cancer Research UK and the National Institute for Health and Care Research (NIHR), is now being rolled out in Lancashire through mobile screening vans based in Penwortham and Preston. Burrows, who has suffered from heartburn for a decade, said he was keen to take part if it could help future patients. "The pill on the thread sounds fascinating," he said. "I'm more than happy to be a guinea pig and help out in a clinical trial if it will help others in the future.